Sonoma Pharmaceuticals Inc. - notizie pubblicate 116 - letture 1.363
SONOMA PHARMACEUTICALS INC.
Sonoma Pharmaceuticals Celebrates 20 Years of Selling Wound Care Products in Europe and Announces New Distributor in Ukraine
July 9, 2024 sonoma pharmaceuticals celebrates 20 years of selling wound care products in europe and announces new distributor in ukraine boulder, co / accesswire / july 9, 2024 /s ...
SONOMA PHARMACEUTICALS INC.
Supplemental Prospectus - Form 424B5
Filed pursuant to rule 424(b)(5) registration no. 333-275311 prospectus supplement (to prospectus dated november 20, 2023) up to $434,102 sonoma pharmaceuticals, inc. common stock ...
SONOMA PHARMACEUTICALS INC.
Material Event Form 8 K
Item 8.01 other events. as previously disclosed, on december 15, 2023, sonoma pharmaceuticals, inc. (the "company") entered into an equity distribution agreement (the &qu ...
SONOMA PHARMACEUTICALS INC.
Statement of Changes in Beneficial Ownership - Form 4
Ownership submission form 4 check this box if no longer subject to section 16, form 4 or form 5 obligations may continue. see instruction 1(b). united states securities and exchang ...
SONOMA PHARMACEUTICALS INC.
Statement of Changes in Beneficial Ownership - Form 4
Ownership submission form 4 check this box if no longer subject to section 16, form 4 or form 5 obligations may continue. see instruction 1(b). united states securities and exchang ...
SONOMA PHARMACEUTICALS INC.
Statement of Changes in Beneficial Ownership - Form 4
Ownership submission form 4 check this box if no longer subject to section 16, form 4 or form 5 obligations may continue. see instruction 1(b). united states securities and exchang ...
SONOMA PHARMACEUTICALS INC.
Statement of Changes in Beneficial Ownership - Form 4
Ownership submission form 4 check this box if no longer subject to section 16, form 4 or form 5 obligations may continue. see instruction 1(b). united states securities and exchang ...
SONOMA PHARMACEUTICALS INC.
Preliminary Proxy Statement - Form PRE 14A
Table of contents united states securities and exchange commission washington, dc 20549 schedule 14a proxy statement pursuant to section 14(a) of the securities exchange act of 193 ...
SONOMA PHARMACEUTICALS INC.
Sonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2024 Financial Results
June 17, 2024 sonoma pharmaceuticals reports fiscal year and fourth quarter 2024 financial results revenues increased 14% in q4 2024 compared to q4 2023 gross profit margin improve ...
SONOMA PHARMACEUTICALS INC.
Annual report pursuant to Section 13 and 15(d)
Table of contents united states securities and exchange commission washington, d.c. 20549 form 10-k (mark one) ☒ annual report pursuant to section 13 or 15(d) of the securities e ...
SONOMA PHARMACEUTICALS INC.
Initial Registration Statement for Employee Benefit Plan Form S 8
United states securities and exchange commission washington, dc 20549 ___________________________ form s-8 registration statement under the securities act of 1933 _________________ ...
SONOMA PHARMACEUTICALS INC.
Annual Report for Fiscal Year Ending March 31, 2024 (Form 10-K)
Sonoma pharmaceuticals, inc. 10-k table of contents united states securities and exchange commission washington, d.c. 20549 form 10-k (mark one) ☒ annual report pursuant to secti ...
SONOMA PHARMACEUTICALS INC.
Sonoma Pharmaceuticals Announces MicrocynAH for Animal Health Now Available Through Menards Home Improvement Stores
May 9, 2024 sonoma pharmaceuticals announces microcynah for animal health now available through menards home improvement stores boulder, co / accesswire / may 9, 2024 /sonoma pharm ...
SONOMA PHARMACEUTICALS INC.
Sonoma Pharmaceuticals Announces Expansion of Negative-Pressure Wound Therapy Products for Use in the United States
April 9, 2024 sonoma pharmaceuticals announces expansion of negative-pressure wound therapy products for use in the united states boulder, co / accesswire /april 9, 2024 / sonoma p ...
SONOMA PHARMACEUTICALS INC.
Sonoma Pharmaceuticals Reports Recent Publication from Australia Highlighting Potential for Microdox in Managing Urinary Tract Infections
April 4, 2024 sonoma pharmaceuticals reports recent publication from australia highlighting potential for microdox in managing urinary tract infections boulder, co / accesswire / a ...
Per i consulenti finanziari
Abbiamo ricevuto 2.400 richieste di consulenza, pubblica il tuo profilo premium
per ricevere contatti e acquisire nuovi clienti